Biomerica Inc. Files Q3 2025 10-Q Report
Ticker: BMRA · Form: 10-Q · Filed: Apr 14, 2025 · CIK: 73290
| Field | Detail |
|---|---|
| Company | Biomerica INC (BMRA) |
| Form Type | 10-Q |
| Filed Date | Apr 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, diagnostics, financials
Related Tickers: BMRA
TL;DR
BIOMERICA (BMRA) filed its Q3 2025 10-Q. Check financials.
AI Summary
Biomerica Inc. filed its 10-Q for the period ending February 28, 2025. The company, previously known as NMS Pharmaceuticals Inc., is based in Irvine, CA, and operates in the in vitro & in vivo diagnostic substances sector. The filing covers the third quarter of their fiscal year, which ends on May 31st.
Why It Matters
This filing provides investors with an update on Biomerica's financial performance and operational status for the third quarter of their fiscal year, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — As a diagnostic substances company, Biomerica operates in a highly regulated and competitive industry, which inherently carries medium risk.
Key Numbers
- Q3 2025 — Fiscal Quarter (Reporting period for the 10-Q filing)
- 0531 — Fiscal Year End (Indicates when the company's fiscal year concludes)
Key Players & Entities
- BIOMERICA INC (company) — Filer of the 10-Q
- NMS PHARMACEUTICALS INC (company) — Former name of BIOMERICA INC
- NUCLEAR MEDICAL SYSTEMS INC (company) — Former name of BIOMERICA INC
- NUCLEAR INSTRUMENTS INC (company) — Former name of BIOMERICA INC
- 20250228 (date) — End of the reporting period
- 20250414 (date) — Filing date
- 0531 (date) — Fiscal year end
- 9493792875 (phone_number) — Business phone number
- 001-37863 (ticker) — SEC File Number
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is February 28, 2025.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted on April 14, 2025.
What is Biomerica Inc.'s fiscal year end date?
Biomerica Inc.'s fiscal year ends on May 31st.
What industry does Biomerica Inc. operate in?
Biomerica Inc. operates in the 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES' sector.
What were some of Biomerica Inc.'s previous company names?
Biomerica Inc. was formerly known as NMS Pharmaceuticals Inc., Nuclear Medical Systems Inc., and Nuclear Instruments Inc.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 14, 2025 regarding BIOMERICA INC (BMRA).